1. Home
  2. VRNA vs INGR Comparison

VRNA vs INGR Comparison

Compare VRNA & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • INGR
  • Stock Information
  • Founded
  • VRNA 2005
  • INGR 1906
  • Country
  • VRNA United Kingdom
  • INGR United States
  • Employees
  • VRNA N/A
  • INGR N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • INGR Packaged Foods
  • Sector
  • VRNA Health Care
  • INGR Consumer Staples
  • Exchange
  • VRNA Nasdaq
  • INGR Nasdaq
  • Market Cap
  • VRNA 8.3B
  • INGR 8.6B
  • IPO Year
  • VRNA 2017
  • INGR 1997
  • Fundamental
  • Price
  • VRNA $105.18
  • INGR $126.40
  • Analyst Decision
  • VRNA Buy
  • INGR Hold
  • Analyst Count
  • VRNA 11
  • INGR 5
  • Target Price
  • VRNA $114.10
  • INGR $151.40
  • AVG Volume (30 Days)
  • VRNA 8.1M
  • INGR 485.7K
  • Earning Date
  • VRNA 08-11-2025
  • INGR 08-01-2025
  • Dividend Yield
  • VRNA N/A
  • INGR 2.53%
  • EPS Growth
  • VRNA N/A
  • INGR 4.50
  • EPS
  • VRNA N/A
  • INGR 10.23
  • Revenue
  • VRNA $118,535,000.00
  • INGR $7,316,000,000.00
  • Revenue This Year
  • VRNA $893.95
  • INGR $3.22
  • Revenue Next Year
  • VRNA $73.76
  • INGR $2.65
  • P/E Ratio
  • VRNA N/A
  • INGR $12.36
  • Revenue Growth
  • VRNA N/A
  • INGR N/A
  • 52 Week Low
  • VRNA $18.51
  • INGR $118.85
  • 52 Week High
  • VRNA $105.50
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 70.25
  • INGR 24.98
  • Support Level
  • VRNA $104.58
  • INGR $131.47
  • Resistance Level
  • VRNA $105.31
  • INGR $134.77
  • Average True Range (ATR)
  • VRNA 0.22
  • INGR 2.50
  • MACD
  • VRNA -0.64
  • INGR -0.55
  • Stochastic Oscillator
  • VRNA 60.49
  • INGR 5.37

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: